Her research goal is to improve the way
we study diseases in pets, such as by developing new methods to scientifically measure symptoms, quality of life, and other outcomes that are important to pets and their families.
Human medical researchers and veterinarians are increasingly working together to
study diseases in dogs, in particular.
We apply personalised functional genomics to
study diseases in patient - derived cells using systematic and targeted approaches to unravel mechanisms and discover novel treatments (see video).
Scientists want to be able to clone early human embryos, using cells from patients with various diseases, so they can
study the diseases in the lab and develop new treatments for them.
These iPS cells are already making it possible to
study diseases in new ways, and they raise the hope of someday using a patient's own cells to treat disease.
This is a good example of the value of
studying a disease in a dish, according to Hunter.
And by creating personalized organoids from the reprogrammed cells of patients, scientists could
study disease in a very individualized way — or maybe even use organoid structures to replace certain damaged tissues, such as in the liver or spinal cord.
«We can now rapidly generate organoids from any patient, which offers us the potential to
study the disease in a much wider population.»
Physician - researchers from the International Mesothelioma Program at Brigham and Women's Hospital (BWH) have been caring for patients with mesothelioma for the past 25 years and, in parallel,
studying the disease in the laboratory to better understand its biology and develop treatment strategies to target its vulnerabilities.
To
study the disease in mice, the animals need to be engineered to produce a human version of IAPP.
For years, researchers had difficulty modeling metastatic prostate cancer in mice, making it hard to
study the disease in the lab.
The genes are likely to be expressed when cells differentiate into neural crest lineages, such as neurons or Schwann cells, thereby enabling researchers to
study the disease in a dish.
A veterinary clinical pathologist is a veterinarian who
studies diseases in animals, examines blood, tissue and fluid samples, and conducts laboratory tests that help to confirm or reveal a diagnosis of what may be wrong with your pet.
Veterinary pathologists
study disease in animals.
Veterinary Clinical Pathology, also referred to as Laboratory Medicine,
studies disease in animals through the examination of blood, tissues, and fluids.
Not exact matches
A
study of increases or decreases
in rates of a
disease across years, calculated for groups of people, is called an ecologic
study.
The Chinese government financed nationwide
studies into cockroaches» medical value that, after more than two decades of laboratory investigation and clinical trials, had discovered or confirmed dozens of
disease - fighting proteins and biochemical compounds with huge potential value
in medicine.
Low - income Americans saw no improvements
in blood pressure, their risk of heart
disease, or a drop
in the share of people who smoke between 2011 and 2014 compared with the period running from 1999 to 2004, according to a
study published
in the journal JAMA Cardiology.
Scanadu will also have anonymized access to all of its users» health data, which can be used for epidemiology — the
study of the patterns of health and
disease in defined geographic areas.
According to a
study in the Canadian Medical Association Journal, artificial sweeteners have been linked to obesity, high blood pressure, diabetes, and heart
disease.
The company runs clinical
studies on behalf of its multinational pharma clients
in oncology, respiratory / infectious
disease and central nervous system disorders.
Most of the health benefits researchers have found have been
in observational
studies, meaning we don't know that drinking coffee is responsible for the reductions
in disease risk.
A
study published
in the American Journal of Preventive Medicine found that the more time subjects spent sitting during the day, the greater their chances of dying from all causes, including cancer and heart
disease.
Inovio's vaccine against HPV is currently
in Phase II clinical
studies, and Kim says «about 50 percent» of the subjects
in that trial are defeating the
disease.
A giant new
study, reported
in the New York Times, found that people who drank between three and five cups of coffee a day had a 15 percent lower risk of dying young from heart
disease and several other medical conditions.
Smoking and physical activity rank number one and two
in the world as the top risk factors for non-communicable
diseases (and inactivity is responsible for 9 % of premature deaths, according to a
study published
in The Lancet).
And while some, like a 2013
study in the journal The Lancet and a 2015 paper
in the journal Nature, have yielded promising clues, none have been able to spot any precise, reliable genetic markers of the
disease.
«So to me it was sort of natural to put dog
studies in the context of human
disease.»
The growing number of people who have the
disease is troubling, because there are only four approved drugs that treat symptoms of the
disease, and several hopeful treatments have failed key
studies in 2017.
The American Beverage Association dismissed the
study in a statement, saying it did «not show that consuming sugar - sweetened beverages causes chronic
diseases and the authors themselves acknowledge that they are at best estimating effects of sugar - sweetened beverage consumption.»
And a variety of
studies are looking at what role the breakdown of tryptophan may play
in aging and age - related
diseases.
In recent years, Levine and others have used clinical studies to prove that even in healthy people, a chair - based lifestyle sets up the physiological conditions for the onset of Type 2 diabetes, cardiovascular disease, obesity — and ultimately, shorter lifespan
In recent years, Levine and others have used clinical
studies to prove that even
in healthy people, a chair - based lifestyle sets up the physiological conditions for the onset of Type 2 diabetes, cardiovascular disease, obesity — and ultimately, shorter lifespan
in healthy people, a chair - based lifestyle sets up the physiological conditions for the onset of Type 2 diabetes, cardiovascular
disease, obesity — and ultimately, shorter lifespans.
That delay translated to a 30 % relative reduction of risk that the
disease would progress or lead to death, according to the
study, which was published
in August
in the New England Journal of Medicine.
Amgen Executive Vice President of Research and Development Sean Harper said the
study was designed to explore Kyprolis dosing regimens, noting that the the trial did not meet its goal
in improving progression - free survival versus Velcade
in patients who had not yet been treated for the
disease.
The
disease management program resulted
in fewer hospital visits for workers, which was a significant factor
in cost reduction, the
study found.
These
studies helped illuminate some of the molecular mechanisms by which these fungal pathogens cause
disease in the banana.
A wealth of recent research, including a new
study published this month
in the Journal of Alzheimer's
Disease, suggests that any type of exercise that raises your heart rate and gets you moving and sweating for a sustained period of time — known as aerobic exercise — has a significant, overwhelmingly beneficial impact on the brain.
Valued for its resistance to heat and corrosion, asbestos was widely used for decades
in such products as building materials, pipe insulation and floor tiles before
studies linked it to lung cancer and other
diseases.
Fernando Pagan, a GUMC associate professor of neurology who directs the Movement Disorders Program at MedStar Georgetown University Hospital, said that to his knowledge, the
study «represents the first time a therapy appears to reverse — to a greater or lesser degree depending on stage of
disease — cognitive and motor decline
in patients with these neurodegenerative disorders.»
Sitting on his patio at his summer house
in Boulder, he pulls out his iPad to forward me an article on a new
study from the Centers for
Disease Control and Prevention that found that only about one
in 10 Americans eats the recommended minimum five servings a day of fruit and vegetables.
Various
studies at the time suspected sugar was bad for the heart, and the latest JAMA suggests the Foundation paid the researchers to counter those arguments and «downplay early warning signs that sucrose consumption was a risk factor
in [coronary heart
disease].»
A new
study from researchers at the University of North Carolina shows that loneliness can «vastly elevate» a person's risk of heart
disease, stroke and cancer, making it as dangerous to your health as a lack of physical inactivity
in youth or diabetes
in old age.
The
studies conducted
in the late 60s that suggested fat intake was a greater risk factor for heart
disease than sugar consumption were actually funded by the Sugar Research Foundation, according to a new analysis published Monday
in JAMA Internal Medicine.
Some recent
studies suggest that diets high
in fructose are linked with several health problems, including heart
disease.
A new, extensive five - year
study on the effects of cocoa flavanols on cardiovascular
disease is slated to begin
in 2015 and will hopefully reveal more about the antioxidant's impact on memory.
In fact, countless
studies have found that increased fruit consumption is tied to lower body weight and a lower risk of obesity - associated
diseases.
The
study provides another example of the role of the microbiome — the collection of microbes found
in and on the body —
in health and
disease.
A 23 - year mortality follow - up
in the Israeli Ischemic Heart
Disease Study
Workplace wellness programs can lower health care costs
in workers with chronic
diseases, but components of the programs that encourage workers to adopt healthier lifestyles may not reduce health costs or lead to lower net savings, according to a new RAND Corporation
study.
The biotech specialist said that its updated phase 2 data
in a
study of its poziotinib candidate treatment for non-small cell lung cancer resulted
in a preliminary confirmed objective response rate and potential progression - free survival benefit
in patients with the EGFR Exon 20 Mutant form of the
disease.